Atopic Clinical Trials in Beijing, Beijing Municipality
13 recruitingBeijing, Beijing Municipality, China
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Atopic Dermatitis
Pfizer500 enrolled37 locationsNCT06807281
Recruiting
Phase 1
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
Atopic Dermatitis
Bambusa Therapeutics99 enrolled10 locationsNCT07239947
Recruiting
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
Atopic Dermatitis (AD)
Chengdu Kangnuoxing Biopharma,Inc.1,000 enrolled1 locationNCT07544862
Recruiting
An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China
Atopic Dermatitis
AbbVie1,000 enrolled38 locationsNCT06421740
Recruiting
Phase 2
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Atopic Dermatitis
Pfizer340 enrolled98 locationsNCT05995964
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases
healthy adult participantsHealthy ParticipantsHealthy Volunteers+4 more
BeiGene211 enrolled13 locationsNCT06342713
Recruiting
Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
AbbVie675 enrolled148 locationsNCT06461897
Recruiting
Phase 2
A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd.403 enrolled1 locationNCT07330934
Recruiting
Phase 2
A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd.120 enrolled1 locationNCT07399067
Recruiting
Phase 3
Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
Dermatitis Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.180 enrolled3 locationsNCT07042126
Recruiting
Phase 2
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Atopic Dermatitis (AD)
Keymed Biosciences Co.Ltd246 enrolled1 locationNCT07230483
Recruiting
Phase 3
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.552 enrolled62 locationsNCT06775860
Recruiting
Phase 3
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Akeso420 enrolled59 locationsNCT06383468